An experimental and clinical study of ayurvedic drug compound pandughni vati on Iron Deficiency Anemia in childre
Phase 2
Completed
- Conditions
- Health Condition 1: E611- Iron deficiencyHealth Condition 2: null- Pandu (Iron Deficiency Anemia)
- Registration Number
- CTRI/2011/12/002310
- Lead Sponsor
- Institute for Post Graduate Teaching and Research in Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
patients presenting with signs and symptoms of Pandu (IDA)having Hb% less than 11.5 g% and microcytic hypochromic anemia in peripheral smear
Exclusion Criteria
patients with hemoglobinopathies, bleeding disorders, malignancy, and other systemic diseases such as Tuberculosis, Juvinile diabetes mellitus etc
Also patients having Hb% less than 6.5 g%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Pandughni Vati's efficacy in treating iron deficiency anemia in children?
How does Pandughni Vati compare to ferrous sulfate in improving hemoglobin levels and iron saturation in pediatric patients?
Which biomarkers (e.g., serum ferritin, transferrin receptor) predict response to Pandughni Vati in iron-deficient children?
What are the safety profiles and management strategies for adverse events associated with Pandughni Vati in clinical trials?
Are there synergistic effects when combining Pandughni Vati with other herbal or conventional therapies for pediatric anemia?